Multi-cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma.

ABSTRACT:

SUBMITTER: Yan J 

PROVIDER: S-EPMC10660794 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature